Balyasny Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAT
Balyasny Asset Management's BEAT Position: Q1 2021 in Review
Balyasny Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 14,419 shares — an estimated $1.04M sold.
Balyasny Asset Management first reported a position in BEAT in Q2 2013 and held it in 10 quarters. The position peaked at $9.9M in Q3 2013. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Balyasny Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Balyasny Asset Management sold 14,419 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.04M.
- Balyasny Asset Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 10 quarters.
- Balyasny Asset Management's BioTelemetry, Inc. position peaked at $9.9M in Q3 2013.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Balyasny Asset Management's 13F filing for Q1 2021, filed 17 May 2021.